Infographic

Despite Tough Year, Outlook Is Strong for M&A in Pharma and Biotech

After a year in which deal value fell across the healthcare sector, pharma and biotech companies are poised for an active 2021.

Companies willing to invest shrewdly in the downturn will emerge from it stronger.

Gaining an edge in a market reset: Bain's annual Global M&A report looks at how turbulent times produce strategic winners and losers.

First published in marzo 2021

Speak to our experts in Please select an industry from the dropdown list

We help global leaders with their organization's most critical issues and opportunities. Together, we create enduring change and results

Your work email address Please enter a valid email address